HBM1020
HBM1020 is a fully human monoclonal antibody targeting B7H7. HBM1020 binds to B7H7 and enhances the anti-tumor response of T cells. HBM1020 can be used in research related to advanced solid tumors.
Para uso exclusivo en investigación. No vendemos a pacientes.
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
Descripciòn
Species Reactivity
Human
IC50 & Target
[1]|
B7H7 |
In Vitro
HBM1020 is a fully human monoclonal antibody targeting B7H7, an immune checkpoint molecule. Due to its high expression in solid tumors and association with poor prognosis, B7H7 emerges as a highly promising target for tumor therapy[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
Gene ID
Accession
Q9UM44
Target
HHLA2
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Product Image
Aplicación
ELISA, FACS, Functional assay
Chemical Information
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
HBM1020 Related Classifications
HY-P992363 Related Classifications
Powered by Bioz